This chart shows the drugs with the most patents in Switzerland. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is desired.…
The post Which pharmaceutical drugs have the most drug patents in Swi…
Which pharmaceutical drugs have the most drug patents in Switzerland? Read Post »
Annual Drug Patent Expirations for INBRIJA Inbrija is a drug marketed by Acorda and is included in one NDA. It is available from one supplier. There are eighteen patents protecting…
The post New patent expiration for Acorda drug INBRIJA appeared first …
Annual Drug Patent Expirations for OFEV Ofev is a drug marketed by Boehringer Ingelheim and is included in one NDA. It is available from one supplier. There are five patents…
The post New patent for Boehringer Ingelheim drug OFEV appeared first on Drug…
Annual Drug Patent Expirations for VITRAKVI Vitrakvi is a drug marketed by Bayer Hlthcare and Bayer Healthcare and is included in two NDAs. It is available from one supplier. There…
The post New patent for Bayer Healthcare drug VITRAKVI appeared first …
This chart shows the pharmaceutical companies with the most patents in Czech Republic. Patents must be filed in each country (or, in some cases regional patent office) where patent protection…
The post Which pharmaceutical companies have the most drug …
Which pharmaceutical companies have the most drug patents in Czech Republic? Read Post »
Annual Drug Patent Expirations for AVEED Aveed is a drug marketed by Endo Pharms Inc and is included in one NDA. It is available from one supplier. There are two…
The post New patent for Endo Pharms drug AVEED appeared first on DrugPatentWatch – Make B…
This chart shows the pharmaceutical companies with the most supplementary protection certificates (SPCs) in Finland. SPCs are used in European Union and select others to encourage pharmaceutical innovation by compensating…
The post Which pharmaceutical…
Which pharmaceutical companies have the most SPCs in Finland? Read Post »
This chart shows the drug companies with the most supplementary protection certificates (SPCs). SPCs are used in European Union and select others to encourage pharmaceutical innovation by compensating for the…
The post Which pharma companies have the m…
Which pharma companies have the most supplementary protection certificates? Read Post »
BEVYXXA (betrixaban) Portola pharms inc Patent: 9,629,831 Expiration: Sep 15, 2020 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact [email protected]…
The post Drug Pa…
Drug Patent Expirations for the Week of September 13, 2020 Read Post »
Annual Drug Patent Expirations for EVOTAZ Evotaz is a drug marketed by Bristol-myers Squibb and is included in one NDA. It is available from one supplier. There are two patents…
The post New patent for Bristol-myers Squibb drug EVOTAZ appeared first on…